Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUO: ICG Permanence in Axillary Lymph Nodes
NCT06347354Not yet recruiting
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Sep 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Permanence of fluorescence at the level of axillary lymph nodes at 3 weeks. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06347354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06347354.